Novel Aryl Sulfonamide Derivatives as NLRP3 Inflammasome Inhibitors for the Potential Treatment of Cancer.
Albanese V, Missiroli S, Perrone M, Fabbri M, Boncompagni C, Pacifico S, De Ventura T, Ciancetta A, Dondio G, Kricek F, Pinton P, Guerrini R, Preti D, Giorgi C.
Albanese V, et al. Among authors: de ventura t.
J Med Chem. 2023 Apr 13;66(7):5223-5241. doi: 10.1021/acs.jmedchem.3c00175. Epub 2023 Mar 27.
J Med Chem. 2023.
PMID: 36972104